SCHEMBL2115805

SCHEMBL2115805

CS(=O)(=O)c1ccc(Cn2ccc3ccc(C(=O)NO)cc3c2=O)cc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 17/20 0.52
HDAC1 Q13547 14/20 0.52
HDAC8 Q9BY41 13/20 0.52
HDAC2 Q92769 12/20 0.52
HDAC3 O15379 10/20 0.52
HDAC10 Q969S8 7/20 0.52
HDAC9 Q9UKV0 6/20 0.52
HDAC11 Q96DB2 5/20 0.52
HDAC4 P56524 5/20 0.52
HDAC7 Q8WUI4 4/20 0.52
HDAC5 Q9UQL6 3/20 0.52
NCOR2 Q9Y618 1/20 0.52
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
RORC P51449 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6167921 0.88 CA1 (0.41) PDE4APDE4BPDE4CPDE4D
SCHEMBL6701010 0.87 CA1 (0.46) HDAC6HDAC1HDAC8HDAC2HDAC3
SCHEMBL2611239 0.86 HDAC6 (0.60) HDAC6HDAC1HDAC8HDAC2HDAC3
SCHEMBL6697454 0.86 RORC (0.51) RORC
SCHEMBL1608641 0.85 HDAC8 (0.70) HDAC6HDAC1HDAC8HDAC2HDAC3
SCHEMBL2117375 0.84 HDAC6 (0.60) HDAC6HDAC1HDAC8HDAC2HDAC3
SCHEMBL2116590 0.84 HDAC6 (0.56) HDAC6HDAC1HDAC8HDAC2HDAC3
SCHEMBL2611339 0.83 HDAC6 (0.74) HDAC6HDAC1HDAC8HDAC2HDAC3
SCHEMBL2118004 0.83 HDAC6 (0.53) HDAC6HDAC1HDAC8HDAC2HDAC3
SCHEMBL6167636 0.83 TP53 (0.51) RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160039789-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. 2016-02-11 US disclosed
US-20160039789-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. 2016-02-11 US disclosed
US-20160039789-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. 2016-02-11 US disclosed
US-8765773-B2 Substituted hydroxamic acids and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-07-01 US disclosed
US-8765773-B2 Substituted hydroxamic acids and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-07-01 US disclosed
US-8765773-B2 Substituted hydroxamic acids and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-07-01 US disclosed
US-20120094997-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-04-19 US disclosed
US-20120094997-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-04-19 US disclosed
US-20120094997-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120094997-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF HDAC6, HDAC1, HDAC5 HDAC6 1/4885HDAC1 2/4885HDAC8 14/4885
US-20160039789-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF HDAC6, HDAC1, HDAC5 HDAC6 1/4885HDAC1 2/4885HDAC8 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.